Lobe Sciences (XCNQ:LOBE) EV-to-EBIT : -3.27 (As of May. 15, 2024)

Lobe Sciences EV-to-EBIT Chart

Lobe Sciences Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Aug19	Aug20	Aug21	Aug22	Aug23
EV-to-EBIT		Get a 7-Day Free Trial					-12.37	-3.75	-1.13	-0.22	-0.49

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
EV-to-EBIT	Get a 7-Day Free Trial															-0.27	-0.18	-0.49	-1.48	-1.74

Competitive Comparison of Lobe Sciences's EV-to-EBIT

For the Biotechnology subindustry, Lobe Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's EV-to-EBIT falls into.

Lobe Sciences EV-to-EBIT Calculation

Lobe Sciences's EV-to-EBIT for today is calculated as:

Lobe Sciences's current Enterprise Value is C$3.66 Mil.
Lobe Sciences's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences  (XCNQ:LOBE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lobe Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

Lobe Sciences's Enterprise Value for the quarter that ended in Feb. 2024 was C$1.95 Mil.
Lobe Sciences's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (XCNQ:LOBE) Business Description